Pawsible Ventures has launched a new pet health incubator aimed at helping early-stage startups navigate funding, regulatory pathways, and commercialization as the global pet economy surpasses $270 billion.
PetSmart reports an 11% surge in dog adoptions at its in-store adoption events, surpassing 90,000 in 2025, as it unveils the 25 U.S. cities showing the strongest commitment to adopting and pampering dogs.
A new Hill’s Pet Nutrition report finds large dogs experience longer shelter stays and lower adoption rates, driven by concerns around cost, size, and adopter confidence.
Zoetis will acquire Neogen’s animal genomics business for $160 million, strengthening its Precision Animal Health capabilities across livestock and companion animals worldwide.
New data from the AVMA’s 2025 Pet Ownership and Demographic Sourcebook show most U.S. pet owners are highly satisfied with their veterinary practice, particularly in areas of staff friendliness, knowledge, and quality of care.
Authorization allows veterinarians to use NexGard® and NexGard® COMBO to treat New World screwworm infestations amid spread in Mexico.
Merck Animal Health has received FDA approval for NUMELVI™ (atinvicitinib tablets), the first and only second-generation JAK inhibitor indicated for control of pruritus associated with allergic dermatitis in dogs six months of age and older.
Cats now represent nearly one in four U.S. veterinary visits, outperforming the broader market and revealing a $34 billion total addressable opportunity, according to CATalyst Council.
Covetrus and MWI Animal Health have entered a definitive agreement to merge, creating a combined company spanning companion and production animal distribution, pharmacy, and technology solutions in a deal valuing MWI at $3.5 billion.
The U.S. FDA has granted an Emergency Use Authorization for IVOMEC® (ivermectin) 1% Injection, marking the first over-the-counter product authorized to help prevent New World screwworm infestations in cattle amid heightened regional surveillance concerns.